日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Clinical and genetic markers of vascular toxicity in glioblastoma patients: Insights from NRG Oncology RTOG-0825

胶质母细胞瘤患者血管毒性的临床和遗传标志物：来自NRG Oncology RTOG-0825研究的启示

期刊:Neuro-Oncology
影响因子:13.4
doi:10.1093/neuonc/noae234
Strauss, Joshua D; Gilbert, Mark R; Mehta, Minesh; Li, Ang; Zhou, Renke; Bondy, Melissa L; Sulman, Erik P; Yuan, Ying; Liu, Yanhong; Vera, Elizabeth; Wendland, Merideth M; Stieber, Volker W; Puduvalli, Vinay K; Choi, Serah; Martinez, Nina L; Robins, H Ian; Hunter, Grant K; Lin, Chi-Fan; Guedes, Vivian A; Richard, Melissa A; Pugh, Stephanie L; Armstrong, Terri S; Scheurer, Michael E
细胞生物学
毒理研究
发表日期：2025
文献求助 收藏

Comprehensive Molecular Analysis in NRG Oncology/RTOG 9813: A Phase 3 Study of Radiation and Temozolomide Versus Radiation and BCNU/CCNU in Anaplastic Astrocytoma

NRG Oncology/RTOG 9813 中的综合分子分析：间变性星形细胞瘤放射治疗联合替莫唑胺与放射治疗联合 BCNU/CCNU 的 III 期研究

期刊:International Journal of Radiation Oncology Biology Physics
影响因子:6.5
doi:10.1016/j.ijrobp.2025.03.043
Fleming, Jessica L; Pugh, Stephanie L; Chang, Susan M; McElroy, Joseph P; Becker, Aline P; Aldape, Kenneth D; Shih, Helen A; Ashby, Lynn Stuart; Hunter, Grant K; Bahary, Jean-Paul; Schultz, Christopher J; Kavanagh, Brian D; Puduvalli, Vinay K; Robins, H Ian; Werner-Wasik, Maria; Mehta, Minesh; Chakravarti, Arnab
细胞生物学
发表日期：2025
文献求助 收藏

Pulsed reduced-dose rate re-irradiation for patients with recurrent grade 2 gliomas

对复发性2级胶质瘤患者进行脉冲式低剂量率再照射

期刊:NeuroOncology Advances
影响因子:4.1
doi:10.1093/noajnl/vdae073
Harari, Colin M; Burr, Adam R; Morris, Brett A; Tomé, Wolfgang A; Bayliss, Adam; Bhatia, Ankush; Grogan, Patrick T; Robins, H Ian; Howard, Steven P
胶质瘤
发表日期：2024
文献求助 收藏

NRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastoma

NRG/RTOG 0837：一项随机、II期、双盲、安慰剂对照试验，研究化疗联合放疗或不联合西地尼布治疗新诊断的胶质母细胞瘤的疗效。

期刊:NeuroOncology Advances
影响因子:4.1
doi:10.1093/noajnl/vdad116
Batchelor, Tracy T; Won, Minhee; Chakravarti, Arnab; Hadjipanayis, Costas G; Shi, Wenyin; Ashby, Lynn S; Stieber, Volker W; Robins, H Ian; Gray, Heidi J; Voloschin, Alfredo; Fiveash, John B; Robinson, Clifford G; Chamarthy, UshaSree; Kwok, Young; Cescon, Terrence P; Sharma, Anand K; Chaudhary, Rekha; Polley, Mei-Yin; Mehta, Minesh P
细胞生物学
发表日期：2023
文献求助 收藏

Case report: Radiographic complete response of radiation-induced glioblastoma to front-line radiotherapy: A report and molecular characterization of two unique cases

病例报告：放射诱发性胶质母细胞瘤对一线放疗的影像学完全缓解：两例独特病例的报告及分子特征分析

期刊:Frontiers in Neurology
影响因子:2.8
doi:10.3389/fneur.2023.1099424
Grogan, Patrick T; Helgager, Jeffrey J; Deming, Dustin A; Howard, Steven P; Jenkins, Robert B; Robins, H Ian
细胞生物学
发表日期：2023
文献求助 收藏

Entrectinib demonstrates prolonged efficacy in an adult case of radiation-refractory NTRK fusion glioblastoma

恩曲替尼在一例成人放射难治性NTRK融合胶质母细胞瘤病例中显示出持久疗效

期刊:NeuroOncology Advances
影响因子:4.1
doi:10.1093/noajnl/vdac046
Grogan, Patrick T; Deming, Dustin A; Helgager, Jeffrey; Ruszkiewicz, Theresa; Baskaya, Mustafa K; Howard, Steven P; Robins, H Ian
细胞生物学
发表日期：2022
文献求助 收藏

A phase II study of dose-dense temozolomide and lapatinib for recurrent low-grade and anaplastic supratentorial, infratentorial, and spinal cord ependymoma

一项针对复发性低级别和间变性幕上、幕下和脊髓室管膜瘤的II期研究，评估了高剂量替莫唑胺联合拉帕替尼的疗效。

期刊:Neuro-Oncology
影响因子:13.4
doi:10.1093/neuonc/noaa240
Gilbert, Mark R; Yuan, Ying; Wu, Jimin; Mendoza, Tito; Vera, Elizabeth; Omuro, Antonio; Lieberman, Frank; Robins, H Ian; Gerstner, Elizabeth R; Wu, Jing; Wen, Patrick Y; Mikkelsen, Tom; Aldape, Kenneth; Armstrong, Terri S
神经科学
发表日期：2021
文献求助 收藏

Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825

独立验证的性别特异性列线图，用于预测新诊断胶质母细胞瘤患者的生存期：NRG Oncology RTOG 0525 和 0825

期刊:Journal of Neuro-Oncology
影响因子:3.1
doi:10.1007/s11060-021-03886-5
Patil, Nirav; Somasundaram, Eashwar; Waite, Kristin A; Lathia, Justin D; Machtay, Mitchell; Gilbert, Mark R; Connor, James R; Rubin, Joshua B; Berens, Michael E; Buerki, Robin A; Choi, Serah; Sloan, Andrew E; Penas-Prado, Marta; Ashby, Lynn S; Blumenthal, Deborah T; Werner-Wasik, Maria; Hunter, Grant K; Flickinger, John C; Wendland, Merideth M; Panet-Raymond, Valerie; Robins, H Ian; Pugh, Stephanie L; Mehta, Minesh P; Barnholtz-Sloan, Jill S
细胞生物学
发表日期：2021
文献求助 收藏

NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma

NRG/RTOG 1122：一项评估贝伐珠单抗联合或不联合trebananib治疗复发性胶质母细胞瘤或胶质肉瘤患者的II期双盲安慰剂对照研究

期刊:Cancer
影响因子:5.1
doi:10.1002/cncr.32811
Lee, Eudocia Q; Zhang, Peixin; Wen, Patrick Y; Gerstner, Elizabeth R; Reardon, David A; Aldape, Kenneth D; deGroot, John F; Pan, Edward; Raizer, Jeffrey J; Kim, Lyndon J; Chmura, Steven J; Robins, H Ian; Connelly, Jennifer M; Battiste, James D; Villano, John L; Wagle, Naveed; Merrell, Ryan T; Wendland, Merideth M; Mehta, Minesh P
细胞生物学
发表日期：2020
文献求助 收藏

Phase I/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02

一项针对复发性胶质母细胞瘤的索拉非尼联合厄洛替尼治疗的I/II期研究，是三臂序贯入组临床试验的一部分：NABTC 05-02

期刊:NeuroOncology Advances
影响因子:4.1
doi:10.1093/noajnl/vdaa124
Chen, Huanwen; Kuhn, John; Lamborn, Kathleen R; Abrey, Lauren E; DeAngelis, Lisa M; Lieberman, Frank; Robins, H Ian; Chang, Susan M; Yung, W K Alfred; Drappatz, Jan; Mehta, Minesh P; Levin, Victor A; Aldape, Kenneth; Dancey, Janet E; Wright, John J; Prados, Michael D; Cloughesy, Timothy F; Wen, Patrick Y; Gilbert, Mark R
细胞生物学
发表日期：2020
文献求助 收藏